Back to NRIX

Redmile Group, LLC → NRIX

Redmile Group, LLC NRIX Position History

Nurix Therapeutics, Inc.

Quarters held
4
Latest value
$187.3M
Q3 2026
Peak value
$187.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$153.5M
Q1 2026$119.9M
Q2 2026$98.8M
Q3 2026$187.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$187.3M7.90M——
Q2 2026$98.8M4.07M——
Q1 2026$119.9M7.73M——
Q4 2025$153.5M8.09M——

Other funds holding NRIX

Other Redmile Group, LLC positions

SRRK

SCHOLAR ROCK HLDG CORP

$445.7M
SRRK

SCHOLAR ROCK HLDG CORP

$237.1M
KRYS

KRYSTAL BIOTECH INC

$234.9M
SRRK

SCHOLAR ROCK HLDG CORP

$230M
KRYS

KRYSTAL BIOTECH INC

$175.5M
KRYS

KRYSTAL BIOTECH INC

$174M
KRYS

KRYSTAL BIOTECH INC

$167.1M
SRRK

SCHOLAR ROCK HLDG CORP

$146.6M